Annexon (ANNX) Change in Acquisitions & Divestments (2021 - 2026)
Annexon (ANNX) posted quarterly Change in Acquisitions & Divestments of $33.0 million for Q1 2026, down 79.31% year-over-year from $159.5 million in Q1 2025, and down 14.29% quarter-over-quarter from $38.5 million in Q4 2025.
Annexon (ANNX) Change in Acquisitions & Divestments (2021 - 2026) Analysis & Trends
Annexon's Change in Acquisitions & Divestments history runs 6 years deep, the most recent figure standing at $33.0 million for Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments fell 79.31% year-over-year to $33.0 million; the TTM figure through Mar 2026 stood at $275.9 million (down 45.0% YoY), while the FY2025 annual figure was $402.4 million, up 10.2% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $33.0 million, down from $38.5 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $173.0 million in Q4 2024, with the low at $22.3 million in Q4 2023.
- The 5-year median for Change in Acquisitions & Divestments is $51.1 million (2023), against an average of $68.1 million.
- The sharpest annual moves came in 2022 and 2026: Change in Acquisitions & Divestments soared 1488.0% in 2022, then tumbled 79.31% in 2026.
- Annexon's Change in Acquisitions & Divestments stood at $23.5 million in 2022, then decreased by 5.11% to $22.3 million in 2023, then jumped by 676.01% to $173.0 million in 2024, then slumped by 77.75% to $38.5 million in 2025, then decreased by 14.29% to $33.0 million in 2026.
- Business Quant data shows ANNX's Change in Acquisitions & Divestments at $33.0 million in Q1 2026, $38.5 million in Q4 2025, and $72.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Annexon | 1.00 Bn | 1.00 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50.00 Mn |
| Jun 30, 2026 | 50.00 Mn |
| Mar 31, 2026 | 33.00 Mn |
| Mar 31, 2026 | 33.00 Mn |
| Dec 31, 2025 | 38.50 Mn |
| Dec 31, 2025 | 38.50 Mn |
| Sep 30, 2025 | 72.60 Mn |
| Sep 30, 2025 | 72.60 Mn |
| Jun 30, 2025 | 131.80 Mn |
| Jun 30, 2025 | 131.80 Mn |
| Mar 31, 2025 | 159.50 Mn |
| Mar 31, 2025 | 159.50 Mn |
| Dec 31, 2024 | 173.05 Mn |
| Dec 31, 2024 | 173.05 Mn |
| Sep 30, 2024 | 99.80 Mn |
| Sep 30, 2024 | 99.80 Mn |
| Jun 30, 2024 | 69.30 Mn |
| Jun 30, 2024 | 69.30 Mn |
| Mar 31, 2024 | 23.00 Mn |
| Mar 31, 2024 | 23.00 Mn |